nach oben

Irish Journal of Medical Science (1971 -)

Erschienen in:

08.02.2018 | Original Article

Attitudes of Irish patients with chronic pain towards medicinal cannabis

verfasst von: Ciaran Rochford, Deirdre Edgeworth, Mohammad Hashim, Dominic Harmon

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Medicinal cannabis use is topical in the media in Ireland. A recent Health Products Regulatory Authority review, however, has recommended against its use for patients with chronic pain. This is despite evidence for its effectiveness in this patient’s cohort and the inadequate pain management of these patients.

Aim

The aim of this study was to evaluate the attitudes of Irish patients with chronic pain towards medicinal cannabis.

Methods

After institutional ethics committee approval, a 12-item questionnaire (excluding demographics) was randomly assigned to patients attending a chronic pain clinic (University Hospital Limerick). The questionnaire was designed to incorporate patient’s attitudes on a variety of medicinal cannabis related topics.

Results

Ninety-six adult patients were surveyed. 88.54% agreed that cannabis should be legalised for chronic pain medicinal purposes. 80.21% believed it would have health benefits for them and 73.96% agreed it would be socially acceptable to use cannabis for this purpose. 33.33% perceived cannabis to be addictive while 68.75% would be willing to try it if prescribed by a medical professional.

Conclusions

The study highlights the attitudes of chronic pain patients in Ireland towards medicinal cannabis. It shows their desire to have medical cannabis legalised for chronic pain and that they view it as a reasonable pain management option.

Nur mit Berechtigung zugänglich

Hall W, Degenhardt L (2007) Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry 20(4):393–397. https://doi.org/10.1097/YCO.0b013e32812144cc CrossRefPubMed

Bostwick JM (2012) Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clin Proc 87(2):172–186. https://doi.org/10.1016/j.mayocp.2011.10.003 CrossRefPubMedPubMedCentral

Rehm J, Fischer B (2015) Cannabis legalization with strict regulation, the overall superior policy option for public health. Clin Pharmacol Ther 97(6):541–544. https://doi.org/10.1002/cpt.93 CrossRefPubMed

Van den Brink W (2008) Forum: decriminalization of cannabis. Curr Opin Psychiatry 21(2):122–126. https://doi.org/10.1097/YCO.0b013e3282f57e04 CrossRefPubMed

Department of Health. Minister Harris announces ‘pivotal step’ on Medicinal Cannabis Access Programme [press release]. 2017. [Accessed: 15/12/2017] [Available from: http://health.gov.ie/blog/press-release/minister-harris-announces-pivotal-step-on-medicinal-cannabis-access-programme-prescribers-patients-and-pharmacists-to-draw-up-guidance-for-the-safe-use-of-cannabis-based-treatment/]

Health Products Regulatory Authority. Cannabis for medical use—a scientific review 2017 [Accessed: 15/12/2017] [Available from: https://www.hpra.ie/docs/default-source/publications-forms/newsletters/cannabis-for-medical-use---a-scientific-review.pdf?sfvrsn=7]

Lynch ME, Ware MA (2015) Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials. J NeuroImmune Pharmacol 10(2):293–301. https://doi.org/10.1007/s11481-015-9600-6 CrossRefPubMed

Breivik H, Collett B, Ventafridda V et al (2016) Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10(4):287–333CrossRef

Khelemsky Y, Goldberg AT, Hurd YL, Winkel G, Ninh A, Qian L, Oprescu A, Ciccone J, Katz DJ (2017) Perioperative patient beliefs regarding potential effectiveness of marijuana (cannabinoids) for treatment of pain: a prospective population survey. Reg Anesth Pain Med 42(5):652–659. https://doi.org/10.1097/AAP.0000000000000654 CrossRefPubMed

10.

Otero MJ, Moreno-Gomez AM, Santos-Ramos B et al (2014) Developing a list of high-alert medications for patients with chronic diseases. Eur J Intern Med 25(10):900–908. https://doi.org/10.1016/j.ejim.2014.10.021 CrossRefPubMed

11.

Williams J, van Ours JC, Grossman M (2016) Attitudes to legalizing cannabis use. Health Econ 25(9):1201–1216. https://doi.org/10.1002/hec.3340 CrossRefPubMed

12.

Single E, Christie P, Ali R (2000) The impact of cannabis decriminalisation in Australia and the United States. J Public Health Policy 21(2):157–186CrossRef

13.

Crowley D, Collins C, Delargy I et al (2017) Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey. Harm Reduct J 14(1):4CrossRef

14.

Nussbaum AM, Boyer JA, Kondrad EC (2011) “But my doctor recommended pot”: medical marijuana and the patient-physician relationship. J Gen Intern Med 26(11):1364–1367. https://doi.org/10.1007/s11606-011-1840-4 CrossRefPubMedPubMedCentral

15.

Berkovic SF (2017) Cannabinoids for epilepsy—real data, at last. N Engl J Med 376(21):2075–2076. https://doi.org/10.1056/NEJMe1702205 CrossRefPubMed

16.

Hall W, Degenhardt L (2009) Adverse health effects of non-medical cannabis use. Lancet 374(9698):1383–1391. https://doi.org/10.1016/S0140-6736(09)61037-0 CrossRefPubMed

17.

Barry MJ, Edgman-Levitan S (2012) Shared decision making—pinnacle of patient-centered care. N Engl J Med 366(9):780–781. https://doi.org/10.1056/NEJMp1109283 CrossRefPubMed

18.

Kondrad E, Reid A (2013) Colorado family physicians’ attitudes toward medical marijuana. J Am Board Fam Med 26(1):52–60. https://doi.org/10.3122/jabfm.2013.01.120089 CrossRefPubMed

19.

Kleber HD, DuPont RL (2012) Physicians and medical marijuana. Am J Psychiatry 169(6):564–568. https://doi.org/10.1176/appi.ajp.2012.12030373 CrossRefPubMed

20.

Grant I, Atkinson JH, Gouaux B, Wilsey B (2012) Medical marijuana: clearing away the smoke. Open Neurol J 6(1):18–25. https://doi.org/10.2174/1874205X01206010018 CrossRefPubMedPubMedCentral

21.

Kahan M, Srivastava A, Spithoff S et al (2014) Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations. Can Fam Physician 60(12):1083–1090PubMedPubMedCentral

22.

Serpell M, Ratcliffe S, Hovorka J et al (2014) A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. Eur J Pain 18(7):999–1012CrossRef

23.

Bostwick JM, Reisfield GM, DuPont RL (2013) Clinical decisions. Medicinal use of marijuana. N Engl J Med 368(9):866–868. https://doi.org/10.1056/NEJMclde1300970 CrossRefPubMed

24.

Jones RT, Benowitz NL, Herning RI (1981) Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol 21 (8–9 Suppl):143s–152s

25.

Barrett P, Bradley C (2016) Attitudes and perceived risk of cannabis use in Irish adolescents. Ir J Med Sci 185(3):643–647. https://doi.org/10.1007/s11845-015-1325-2 CrossRefPubMed

26.

Broyd SJ, van Hell HH, Beale C, Yucel M, Solowij N (2016) Acute and chronic effects of cannabinoids on human cognition—a systematic review. Biol Psychiatry 79(7):557–567. https://doi.org/10.1016/j.biopsych.2015.12.002 CrossRefPubMed

27.

Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M et al (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370(9584):319–328CrossRef

28.

Vicente J, Wiessing L (2007) European Monitoring Centre for Drugs and Drug Addiction annual report 2007: positive assessment of HIV in IDUs though hepatitis C still very high. Euro Surveill 12(11):E071122.6PubMed

29.

Menghrajani P, Klaue K, Dubois-Arber F et al (2005) Swiss adolescents’ and adults’ perceptions of cannabis use: a qualitative study. Health Educ Res 20(4):476–484CrossRef

30.

Colorado Department of Public Health and Environment. The Colorado Medical Marijuana Registry 2017. [Accessed 15/12/2017] [Available from: https://www.colorado.gov/pacific/cdphe/2017-medical-marijuana-registry-statistics]

31.

Russo EB, Guy GW, Robson PJ (2007) Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem Biodivers 4(8):1729–1743. https://doi.org/10.1002/cbdv.200790150 CrossRefPubMed

32.

Whiting PF, Wolff RF, Deshpande S, di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, Schmidlkofer S, Westwood M, Kleijnen J (2015) Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 313(24):2456–2473. https://doi.org/10.1001/jama.2015.6358 CrossRefPubMed

33.

Lynch ME (2011) The need for a Canadian pain strategy. Pain Res Manag n 16(2):77–80. https://doi.org/10.1155/2011/654651 CrossRef

Titel: Attitudes of Irish patients with chronic pain towards medicinal cannabis
verfasst von: Ciaran Rochford
Deirdre Edgeworth
Mohammad Hashim
Dominic Harmon
Publikationsdatum: 08.02.2018
Verlag: Springer London
Erschienen in: Irish Journal of Medical Science (1971 -) / Ausgabe 1/2019
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI: https://doi.org/10.1007/s11845-018-1761-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Background

Aim

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Breast screening in symptomatic women over 35 years of age: improvements in service efficiency

The effect of CYP1A2 genotype on the ergogenic properties of caffeine during resistance exercise: a randomized, double-blind, placebo-controlled, crossover study

Coeliac screening in a high-risk population: paediatric type 1 diabetes—a review of current guidelines and practice

Future career intentions of higher specialist trainees in general Paediatrics

Cholesterol screening and statin use in children: a literature review